Status:

COMPLETED

Connected Ovulation Test Efficacy Study

Lead Sponsor:

SPD Development Company Limited

Conditions:

Pregnancy

Eligibility:

FEMALE

18-40 years

Phase:

NA

Brief Summary

Clearblue Connected Ovulation Test System (COTS) has been designed for home use by women who are either planning or trying for a pregnancy. This study will determine the difference in pregnancy rate o...

Eligibility Criteria

Inclusion

  • Actively trying to conceive
  • At least 2 regular consecutive cycles since last pregnancy/ miscarriage/ or since stopping breastfeeding
  • Willing to use their own smartphone for the duration of this study and to download and install the study app
  • Willing to disclose their pregnancy status and provide urine samples to test markers related to pregnancy and fertility
  • Have internet access on their phone for the duration of the study
  • Willing to give informed consent and comply with the investigational procedures

Exclusion

  • Currently or previously employed by SPD, Alere, Abbott, Unipath or P\&G, or affiliates
  • Has an immediate relative\* currently or previously employed by SPD, Alere, Abbott, Unipath or P\&G or affiliates
  • There is a reason why the volunteer should not get pregnant e.g. they are taking a medication or have a medical condition which means they should not get pregnant
  • Trying to conceive for more than 6 months (if less than 35 years old) and more than 3 months (if 35 years old or over)
  • Has been diagnosed with Polycystic Ovarian Syndrome (PCOS)
  • Has PCOS symptoms: very irregular cycles, hirsutism
  • Using or has previously used infertility medications or hormone replacement therapy containing hCG or LH (e.g Pregnyl)
  • Are taking clomiphene citrate or other ovulation induction drugs
  • Using any treatment which may affect the menstrual cycle (e.g. the contraceptive pill)
  • Currently pregnant or breastfeeding
  • Peri- or post-menopausal, e.g. experiencing symptoms: Irregular menstrual periods, hot flushes, night sweats, sleep disturbances, and mood swings
  • Have abnormal liver or kidney function
  • Taking medication containing tetracycline
  • Using or undergoing any other medical treatment for fertility such as ovulation drugs, artificial insemination and assisted fertility such as IVF or ICSI
  • Has a phone that is known to be incompatible with COTS

Key Trial Info

Start Date :

January 29 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 19 2018

Estimated Enrollment :

1000 Patients enrolled

Trial Details

Trial ID

NCT03424590

Start Date

January 29 2018

End Date

September 19 2018

Last Update

October 19 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

SPD Development Company Ltd

Bedford, Bedfordshire, United Kingdom, MK44 3UP